Association between mannose-binding lectin and interleukin-1 receptor antagonist gene polymorphisms and recurrent vulvovaginal candidiasis

Imagem de Miniatura
Arquivos
art_WOJITANI_Association_between_mannose_binding_lectin_and_interleukin_1_2012.PDF (218.53 KB)
Citações na Scopus
27
Tipo de produção
article
Data de publicação
2012
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER HEIDELBERG
Autores
Citação
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, v.285, n.1, p.149-153, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective The influence of functional polymorphisms in the genes coding for mannose-binding lectin (MBL) and interleukin-1 receptor antagonist (IL-1ra) on recurrent vulvovaginal candidiasis (RVVC) were examined in an urban Brazilian population. Methods DNA was isolated from buccal swabs of 100 women with RVVC and 100 control women and tested by gene amplification for a single nucleotide polymorphism in codon 54 of the MBL2 gene and for a length polymorphism in intron 2 of the IL1RN gene. Genotype and allele frequencies were compared between groups. Results The frequency of the variant MBL2 B allele, associated with reduced circulating and vaginal MBL concentrations, was 27.0% in RVVC and 8.5% in control women (p < .0001). The MBL2 B, B genotype was present in 12% of RVVC patients and 1% of controls (p = .0025). The IL1RN 2 allele frequency, associated with the highest level of unopposed IL-1 beta activity, was 24.0% in RVVC and 23.4% in controls. The IL1RN genotype distribution was also similar in both groups. Conclusion Carriage of the MBL2 codon 54 polymorphism, but not the IL1RN length polymorphism, predisposes to RVVC in Brazilian women.
Palavras-chave
Recurrent vulvovaginal candidiasis, Mannose-binding lectin, Interleukin-1 receptor antagonist, Genetic polymorphism
URI
https://observatorio.fm.usp.br/handle/OPI/831
Referências
  1. Babula O, 2005, CLIN INFECT DIS, V40, P1258, DOI 10.1086/429246
  2. Babula O, 2003, CLIN INFECT DIS, V37, P733, DOI 10.1086/377234
  3. Dinarello CA, 1996, BLOOD, V87, P2095
  4. Donders GGG, 2008, BJOG-INT J OBSTET GY, V115, P1225, DOI 10.1111/j.1471-0528.2008.01830.x
  5. Duarte G, 1998, J BRASILEIRO DOENCAS, V10, P4
  6. Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324
  7. Fidel PL, 1996, CLIN MICROBIOL REV, V9, P335
  8. Fidel PL, 2004, TRENDS MICROBIOL, V12, P220, DOI 10.1016/j.tim.2004.03.006
  9. Fidel PL, 2007, AM J REPROD IMMUNOL, V57, P2, DOI 10.1111/j.1600-0897.2006.00450.x
  10. Genc MR, 2002, AM J OBSTET GYNECOL, V187, P157, DOI 10.1067/mob.2002.122407
  11. Giraldo PC, 2007, OBSTET GYNECOL, V109, P1123, DOI 10.1097/01.AOG.0000260386.17555.a5
  12. KALOKLEIN A, 1990, INFECT IMMUN, V58, P260
  13. Lillegard JB, 2006, J INFECT DIS, V193, P1589, DOI 10.1086/503804
  14. MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962
  15. Nawrot U, 2000, FEMS IMMUNOL MED MIC, V29, P89, DOI 10.1016/S0928-8244(00)00191-7
  16. SOBEL JD, 1985, AM J OBSTET GYNECOL, V152, P924
  17. TARLOW JK, 1993, HUM GENET, V91, P403
  18. Babovic-Vuksanovic D, 1999, ANN ALLERG ASTHMA IM, V82, P134, DOI 10.1016/S1081-1206(10)62586-0
  19. Vamvakopoulos J, 2002, EUR J IMMUNOL, V32, P2988, DOI 10.1002/1521-4141(2002010)32:10<2988::AID-IMMU2988>3.0.CO;2-9
  20. Weissenbacher T, 2009, ARCH GYNECOL OBSTET, V279, P125, DOI 10.1007/s00404-008-0681-9
  21. WITKIN SS, 1988, J ALLERGY CLIN IMMUN, V81, P412, DOI 10.1016/0091-6749(88)90909-8
  22. WITKIN SS, 2000, IT J GYNECOL OBSTET, V3, P114
  23. Witkin SS, 2000, AM J OBSTET GYNECOL, V183, P252, DOI 10.1067/mob.2000.104258

Coleções
Artigos e Materiais de Revistas Científicas - FM/MOG
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/58